GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Total Assets

UPB (Upstream Bio) Total Assets : $481.72 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Total Assets?

Upstream Bio's Total Assets for the quarter that ended in Dec. 2024 was $481.72 Mil.

During the past 12 months, Upstream Bio's average Total Assets Growth Rate was 52.50% per year.

Total Assets is connected with ROA %. Upstream Bio's annualized ROA % for the quarter that ended in Dec. 2024 was -23.79%. Total Assets is also linked to Revenue through Asset Turnover. Upstream Bio's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Upstream Bio Total Assets Historical Data

The historical data trend for Upstream Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Total Assets Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Total Assets
18.48 117.20 481.72

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Total Assets Get a 7-Day Free Trial - 117.20 244.51 232.70 481.72

Upstream Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Upstream Bio's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=469.852+11.867
=481.72

Upstream Bio's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=469.852+11.867
=481.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Upstream Bio  (NAS:UPB) Total Assets Explanation

Total Assets is connected with ROA %.

Upstream Bio's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=-84.968/( (232.7+481.719)/ 2 )
=-84.968/357.2095
=-23.79 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Upstream Bio's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0.613/( (232.7+481.719)/ 2 )
=0.613/357.2095
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Upstream Bio Total Assets Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Upstream Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Total Assets
Comparable Companies
RAPP RNAC TRDA CELC DNA SANA TECX STOK RGNX HRTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Website
https://www.upstreambio.com
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.